Specifically, it can inhibit angiogenesis in gastric cancer by suppressing the secretion of VEGF, which depends on the expression of Notch1, ultimately leading to a reduction in the migration and proliferation of gastric cancer cells. The gene discussed is VEGFA; the disease is gastric cancer.